Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Taltz (ixekizumab) and Otezla (apremilast) are both medications used to treat psoriasis and psoriatic arthritis. However, they belong to different medication classes and have some important differences. Taltz (ixekizumab) is an interleukin antagonist given as a subcutaneous injection, while Otezla (apremilast) is a phosphodiesterase-4 (PDE-4) inhibitor taken orally. Taltz is also approved for ankylosing spondylitis and non-radiographic axial spondyloarthritis, whereas Otezla is used for mouth sores from Behçet’s disease. Taltz is administered every 4 weeks after initial doses, while Otezla is taken by mouth twice daily after initial doses. Taltz does not have a generic version available, whereas generic versions of Otezla have been FDA-approved but are not yet on the market. Common side effects of Taltz include upper respiratory infections and injection-site reactions, while Otezla may cause diarrhea, nausea, and headaches. Some medications can keep Otezla from working as well. Be sure your prescriber and pharmacist have a complete list of your medications.
Taltz (ixekizumab)
Otezla (apremilast)
Taltz (ixekizumab)
Otezla (apremilast)
Summary of Taltz vs. Otezla
Summary for Interleukin antagonist
Prescription only
Taltz (ixekizumab) is an injection that's given under the skin. It helps treat inflammatory conditions, including plaque psoriasis, psoriatic arthritis, and some types of arthritis in the spine. This medication works as an interleukin antagonist to lessen inflammation in the body. You inject Taltz (ixekizumab) once a month using the prefilled syringe or autoinjector. The dose depends on the health problem you're treating. Side effects include upper respiratory infections. You also might feel pain or have redness around the injection area. Taltz (ixekizumab) is a brand-name medication.
Summary for PDE-4 inhibitor
Prescription only
Otezla (apremilast) is a tablet that's taken by mouth. It's used to treat plaque psoriasis, psoriatic arthritis, and mouth sores from Behçet’s disease. This medication belongs to the drug class called phosphodiesterase-4 (PDE-4) inhibitors. You usually start Otezla (apremilast) at a low dose. Then, the dose is slowly raised over 5 days to lower the risk of side effects like nausea and diarrhea. This medication is available as a brand-name medication. Generic versions of apremilast likely won't be available until at least 2028.
Indications of Taltz vs. Otezla
Indications for
•Moderate-to-severe plaque psoriasis in people 6 years and older